3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Ovarian Neoplasms
32
Breast Neoplasms
18
Neoplasms
9
Triple Negative Breast Neoplasms
8
Neoplasm Metastasis
7
Sarcoma
6
Prostatic Neoplasms
6
Fanconi Anemia, Complementation Group D1
6
Pancreatic Neoplasms
5
Endometrial Neoplasms
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Small Cell Lung Carcinoma
4
Recurrence
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Mesothelioma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Advanced Solid Tumours
2
Advanced Solid Tumors
2
Wilms Tumor
1
Interventions
Radiotherapy
16
Amifostine
7
Radiotherapy, Intensity-Modulated
6
Cisplatin
6
Paclitaxel
4
Donepezil
4
sargramostim
3
Radiosurgery
3
Low-Level Light Therapy
3
Filgrastim
3
Etoposide
3
Carboplatin
3
Surveys and Questionnaires
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Esophagectomy
2
Diet Therapy
2
Chemotherapy, Adjuvant
2
Brachytherapy
2
Bevacizumab
2
olaparib
1
ethanethiol
1
delta 24-sterol reductase
1
cevimeline
1
beta Carotene
1
alpha-Tocopherol
1
Zinc Sulfate
1
Vitamin E
1
Vincristine
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Radiation Injuries
×
olaparib
×
Clear all
NCT03109080
2025-11-24
RadioPARP
Institut Curie
Phase 1
Completed
24 enrolled